What are the top competitors of ROSE.SW in Healthcare sector?

The top competitors of ROSE.SW in the Healthcare sector are: Bristol-Myers Squibb Company (BMY.SW), Biogen Inc. (BIIB.SW), DocMorris AG (DOCM.SW).

Which has better valuations & earnings, ROSE.SW or its competitors?

ROSE.SW has a market cap of 404.49M and a Dividend Yield of N/A compared to its competitors.

Which stock is more profitable: ROSE.SW or its competitors?

ROSE.SW has an EPS of $-15.35, while BMY.SW has an EPS of $2.76. So, ROSE.SW is more profitable compared to BMY.SW.

What is ROSE.SW stock volatility and risk in terms of investment?

ROSE.SW has daily volatility of 0% as compared to its competitor BMY.SW which is 0%. ROSE.SW is less volatile as compared to competitors and has low risk.

Is ROSE.SW stock profitable?

ROSE.SW has a Return on Equity (ROE) of -0.26%. So, ROSE.SW is more profitable.

What is ROSE.SW stock’s 52 weeks high and low?

ROSE.SW stock has a 52-week high of ($35.02) and a low of ($35.02).

What was the average volume of ROSE.SW stock?

The average volume of ROSE.SW is (N/A) in terms of investment.

DocMorris AG (ROSE.SW) Competitors

DocMorris AG ROSE.SW Peers

See (ROSE.SW) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
ROSE.SW	$35.02	N/A	404.49M	-2.28	-$15.35	N/A
BMY.SW	$44.50	N/A	73.96B	16.13	$2.76	N/A
BIIB.SW	$232.00	N/A	30.04B	24.54	$9.45	N/A
DOCM.SW	$17.79	-7.63%	210.22M	-2.16	-$8.25	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ROSE.SW vs BMY.SW Comparison

ROSE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ROSE.SW stands at 404.49M. In comparison, BMY.SW has a market cap of 73.96B. Regarding current trading prices, ROSE.SW is priced at $35.02, while BMY.SW trades at $44.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ROSE.SW currently has a P/E ratio of -2.28, whereas BMY.SW's P/E ratio is 16.13. In terms of profitability, ROSE.SW's ROE is -0.26%, compared to BMY.SW's ROE of -0.23%. Regarding short-term risk, ROSE.SW and BMY.SW have similar daily volatility (0.00).

DocMorris AG